GeneQuantum and WuXi XDC have entered into strategic cooperation to empower innovative bioconjugates development
SUZHOU, China, Dec. 26, 2022 /PRNewswire/ -- GeneQuantum Healthcare (GQ), a global innovative biotechnology company dedicated to the development of the next generation bioconjugate drugs , and WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that they have entered into a strategic collaboration for conjugation technology licensing and ADC drug development. According to the...
The documentary “VENICE AND DUNHUANG – Above Desert and Sea” released at the end of the year on CCTV Documentary Channel
BEIJING, Dec. 26, 2022 /PRNewswire/ -- The exhibition "Pearls on the Silk Road: Dunhuang Grottoes in Venice" debuted on February 21, 2018, in the gallery of the University of Venice in Italy. The exhibition transported Italians, who live more than 6,400 kilometers away from Dunhuang, to the allure of art created there 1,600 years ago. "VENICE AND DUNHUANG...
PM-International donates €1,872,000 to charity sponsoring 5,200 children around the world
SCHENGEN, Luxembourg, Jan. 31, 2023 /PRNewswire/ -- PM-International is thrilled to announce that its charity arm known as "PM We Care" is pushing the boundaries for 2023 by donating €1,872,000, the most it has ever given, to support the health, education and a good environment for thousands of children in partnership with the international aid organisation World Vision. The...
Kelun-Biotech announces that a Phase III clinical trial of core product SKB264 (MK-2870, TROP2-ADC) in patients with unresectable locally advanced, recurrent or metastatic TNBC who have failed second-line or...
CHENGDU, China, Aug. 14, 2023 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. ("Kelun-Biotech", HKEX: 6990.HK) announced today that its innovative TROP2-ADC (SKB264, also known as MK-2870) met the primary endpoint in the randomized, controlled, open-label, multi-center Phase III clinical trial of SKB264 for injection versus investigator selected regimens in patients with unresectable locally advanced, recurrent or metastatic triple-negative...
Think City Launches Grants Programme for Recovery and to Boost Creative Economy as First Step in Building Creative and Cultural District in Kuala Lumpur
KUALA LUMPUR, Malaysia, Sept. 21, 2021 /PRNewswire/ -- Think City, an urban impact organisation, has launched the Downtown Kuala Lumpur Grants Programme to enable communities to participate in the recovery and transformation of the historic centre of Kuala Lumpur into a creative and cultural district. The programme, open for submissions from today till October 31, 2021, is rooted in...
Renren Announces Signing of Stipulation of Settlement Regarding Shareholder Derivative Litigation
PHOENIX, Oct. 9, 2021 /PRNewswire/ -- Renren Inc. (NYSE: RENN) ("Renren" or the "Company"), a SaaS company, today announced that it has entered into a Stipulation of Settlement (the "Stipulation") as a nominal defendant with respect to the consolidated shareholder derivative lawsuits currently pending in New York State Supreme Court, Commercial Division (the "Court") under the caption In re Renren, Inc. Derivative Litigation,...
Hellenic Ministry of Culture and Sport and Microsoft partner to digitally preserve ancient site of Olympia
OLYMPIA, Greece, Nov. 10, 2021 /PRNewswire/ -- The Hellenic Ministry of Culture and Sport and Microsoft Corp. on Wednesday announced Ancient Olympia: Common Grounds, a new collaboration to digitally preserve and restore ancient Olympia, the original home of the Olympic games, using AI. This digital revival project allows viewers around the world...
Endurance Longevity Signed Exclusive Licence Agreement to Commercialise Fortacin™ in the Israeli and Balkan regions
HONG KONG, Dec. 15, 2021 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) announced that Plethora Solutions Limited (Solutions), a wholly owned subsidiary of the Company has entered into an exclusive Licence Agreement with K.S. KIM International (SK-Pharma) Ltd. on 14 December 2021 in respect of the rights to...
HotForex scoops six prestigious awards
The highly coveted prizes add to the broker's remarkable achievements and outstanding presence in the forex industry. PORT LUIS, Mauritius, Dec. 15, 2021 /PRNewswire/ -- Multi-asset broker HotForex received six new industry awards, in recognition to the company's outstanding consistency in providing excellent trading conditions to its clients and partners around...
LG Display to Showcase Innovative Flexible OLED Solutions at CES 2022
SEOUL, South Korea, Dec. 23, 2021 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today that it will be demonstrating how its flexible OLED technology creates new and different lifestyles at CES 2022. This year, the company will showcase two new product concepts to the world – "Virtual Ride" and "Media Chair." By introducing these two innovative...









